Aclaris Therapeutics, Inc.ACRSNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank25
3Y CAGR-23.9%
5Y CAGR-2.0%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-23.9%/yr
vs -5.6%/yr prior
5Y CAGR
-2.0%/yr
Recent deceleration
Acceleration
-18.3pp
Decelerating
Percentile
P25
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $19.96M | -18.8% |
| 2024 | $24.57M | -38.4% |
| 2023 | $39.88M | -11.9% |
| 2022 | $45.28M | +65.6% |
| 2021 | $27.35M | +24.0% |
| 2020 | $22.06M | -35.5% |
| 2019 | $34.19M | -40.0% |
| 2018 | $57.02M | -72.7% |
| 2017 | $208.85M | +592.2% |
| 2016 | $30.17M | - |